GLIM-Defined Malnutrition in Patients with Head and Neck Cancer during the Qualification Visit for Home Enteral Nutrition.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
24 Jan 2022
Historique:
received: 08 01 2022
revised: 19 01 2022
accepted: 20 01 2022
entrez: 12 3 2022
pubmed: 13 3 2022
medline: 16 3 2022
Statut: epublish

Résumé

Patients with head and neck cancer (HNC) present multiple symptoms that increase the risk of malnutrition. Nutritional care, including enteral nutrition (EN), plays a crucial role in the management of this group of patients. The aim of the study was to determine the Global Leadership Initiative on Malnutrition (GLIM)-based stages of malnutrition and the relationship with selected biochemical parameters during the home enteral nutrition (HEN) qualification visit of patients with HNC. The retrospective analysis involved 224 patients with HNC referred for HEN. The following parameters were evaluated: body mass index (BMI), percent weight loss, and laboratory tests (serum albumin, total serum protein, C-reactive protein (CRP), and total lymphocyte count (TLC)). Malnutrition was defined using GLIM-based criteria. The prevalence of malnutrition based on GLIM criteria was 93.75% (15.18% moderately malnourished, 78.57% severely malnourished). There was a positive correlation between malnutrition based on GLIM criteria, serum albumin, and CRP. In the model assessing the odds of severe malnutrition according to the criteria of GLIM, TLC and CRP had a statistically significant effect on the chance in the probability of qualifying a patient to the severe malnutrition group, but the strength of the results was weak. The prevalence of malnutrition in HNC patients enrolled to HEN is high and most of them are severely malnourished. This suggests that it is important to identify more efficiently patients with risk of malnutrition at an earlier stage. GLIM criteria for malnutrition can be easily applied in this group of patients, but the definition of inflammation criteria should be clarified.

Identifiants

pubmed: 35276861
pii: nu14030502
doi: 10.3390/nu14030502
pmc: PMC8840501
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

JPEN J Parenter Enteral Nutr. 2014 Feb;38(2):196-204
pubmed: 24748626
Cancer Treat Res. 2018;174:187-208
pubmed: 29435843
Eur Arch Otorhinolaryngol. 2015 Dec;272(12):3793-9
pubmed: 25534287
Front Oncol. 2020 Mar 06;10:146
pubmed: 32211311
Nutrition. 2021 Mar;83:111072
pubmed: 33360034
JPEN J Parenter Enteral Nutr. 2012 Mar;36(2):197-204
pubmed: 21799187
Br J Nutr. 2020 Nov 28;124(10):1069-1075
pubmed: 32618518
ESMO Open. 2021 Jun;6(3):100092
pubmed: 34144781
Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Feb;130(1):8-14
pubmed: 23266003
J Oral Maxillofac Surg. 2013 Nov;71(11):1853-60
pubmed: 23845698
Clin Nutr. 2020 Sep;39(9):2872-2880
pubmed: 32563597
Cancer Manag Res. 2021 Aug 29;13:6775-6783
pubmed: 34512017
Clin Nutr ESPEN. 2020 Jun;37:100-106
pubmed: 32359730
Braz J Otorhinolaryngol. 2021 Apr 9;:
pubmed: 33875388
Cancer Treat Rev. 2016 Apr;45:105-19
pubmed: 27010487
Nutr Clin Pract. 2021 Feb;36(1):22-28
pubmed: 33125793
Clin Nutr ESPEN. 2020 Dec;40:149-155
pubmed: 33183529
Cancer Radiother. 2021 Nov 9;:
pubmed: 34772603
Clin Nutr. 2020 Jan;39(1):5-22
pubmed: 31255350
Support Care Cancer. 2019 Jan;27(1):239-247
pubmed: 29938330
Clin Transl Oncol. 2019 Jan;21(1):87-93
pubmed: 30617923
J Cancer Surviv. 2018 Aug;12(4):479-494
pubmed: 29556926
Nutrients. 2021 Jan 18;13(1):
pubmed: 33477640
Clin Nutr. 2021 Jun;40(6):3741-3747
pubmed: 34130019
Int Immunopharmacol. 2021 Nov;100:108128
pubmed: 34537483
Clin Nutr. 2021 May;40(5):2898-2913
pubmed: 33946039
J Mycol Med. 2018 Jun;28(2):361-366
pubmed: 29602636
Clin Nutr. 2021 Aug;40(8):5030-5037
pubmed: 34365037
Prim Care. 1994 Mar;21(1):55-67
pubmed: 8197257
JPEN J Parenter Enteral Nutr. 2020 Aug;44(6):992-1003
pubmed: 32529700
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):207-217
pubmed: 30920778

Auteurs

Zuzanna Przekop (Z)

Department of Clinical Dietetics, Faculty of Health Sciences, Medical University of Warsaw, 01-445 Warsaw, Poland.

Magdalena Milewska (M)

Department of Clinical Dietetics, Faculty of Health Sciences, Medical University of Warsaw, 01-445 Warsaw, Poland.

Dorota Szostak-Węgierek (D)

Department of Clinical Dietetics, Faculty of Health Sciences, Medical University of Warsaw, 01-445 Warsaw, Poland.

Mariusz Panczyk (M)

Department of Education and Research in Health Sciences, Faculty of Health Sciences, Medical University of Warsaw, 00-681 Warsaw, Poland.

Jacek Sobocki (J)

Department of General Surgery and Clinical Nutrition, Centre of Postgraduate Medical Education, 00-401 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH